Search results for “Fibroblast growth factor receptor 2” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 229 patents, we discovered top 57 key players by total patent application. Five Prime Therapeutics, Inc., Galaxy Biotech LLC, Ionis Pharmaceuticals, Inc. are dominant in this area. They take 52.84% of the total patent filing.
Five Prime Therapeutics, Inc.
California, United States
Patent: 70
Galaxy Biotech LLC
California, United States
Patent: 32
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 19
Novartis AG
Basel-Stadt, Switzerland
Patent: 15
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 10
OncoPlex Diagnostics, Inc.
United States
Patent: 8
ZymoGenetics, Inc.
Washington, United States
Patent: 7
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Allergan, Inc.
California, United States
Patent: 4
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 11
STARTUP
Epsilon Molecular Engineering, Inc.
Saitama-ken, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 69 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Five Prime Therapeutics, Inc., Dana-Farber Cancer Institute, Inc., Regeneron Pharmaceuticals, Inc. take 65.22% of patent filing during this period.
Five Prime Therapeutics, Inc.
California, United States
Patent: 32
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Galaxy Biotech LLC
California, United States
Patent: 5
Regents of The University of Michigan
Michigan, United States
Patent: 4
The Broad Institute, Inc.
Massachusetts, United States
Patent: 3
Sekisui Chemical Co., Ltd.
Osaka-fu, Japan
Patent: 1
Qingdao Hailanshen Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 1
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 1
Jiangsu Shenji Biotechnology Co., Ltd
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 69 patents in last 5 years, we discover 14 new entrants. Dana-Farber Cancer Institute, Inc., Regeneron Pharmaceuticals, Inc., Regents of The University of Michigan are the most active new entrants in this area.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Regents of The University of Michigan
Michigan, United States
Patent: 4
The Broad Institute, Inc.
Massachusetts, United States
Patent: 3
Sekisui Chemical Co., Ltd.
Osaka-fu, Japan
Patent: 1
Qingdao Hailanshen Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 1
Jiangsu Shenji Biotechnology Co., Ltd
Jiangsu Sheng, China
Patent: 1
Univ of Pittsburgh
United States
Patent: 1
Wigen Biomedicine technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 1
The Children's Medical Center Corp.
Massachusetts, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 40 patents, we discovered top 13 universities and scientific research institutions by total patent application. Université Toulouse III - Paul Sabatier, New York University, Université de Paris 5 René Descartes are dominant in this area. They take 57.50% of the total patent filing.
Université Toulouse III - Paul Sabatier
France
Patent: 5
New York University
New York, United States
Patent: 4
Université de Paris 5 René Descartes
France
Patent: 2
Université Paris Diderot-Paris 7
France
Patent: 2
Université Côte dAzur
France
Patent: 2
Duke University
North Carolina, United States
Patent: 1
University of California
California, United States
Patent: 1
University of Florida
United States
Patent: 1
University of Tokyo
Tokyo-to, Japan
Patent: 1
Jinan University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: